Literature DB >> 27819690

Pregnancy outcome following hematopoietic cell transplantation for thalassemia major.

S Santarone1, A Natale1, P Olioso1, D Onofrillo1, C D'Incecco2, G Parruti3, P Di Bartolomeo1.   

Abstract

The aim of this study was to investigate the methods of conception and delivery, as well as the course and outcome of 42 pregnancies occurring in 15 female patients (27 pregnancies) and partners of 8 male patients (15 pregnancies) with β-thalassemia major who were successfully treated with allogeneic hematopoietic cell transplantation (HCT). Most pregnancies (n=21) were achieved with spontaneous conception in female patients. There were two miscarriages. Five pregnancies were late preterm. Delivery was vaginal in 4 cases and by caesarean section in 18. Overall, 22 term pregnancies resulted in successful deliveries of 23 neonates. Two of 23 neonates were symmetrical small for gestational age / intrauterine growth restriction. All 15 pregnancies that occurred in partners of men who received an allogeneic HCT were achieved with spontaneous conception. No miscarriage was observed. Overall, 14 term pregnancies resulted in successful deliveries of 14 live-born singletons. Delivery was vaginal in nine cases and by caesarean section in five. All infants were full-term. Many patients with β-thalassemia major who received an allogeneic HCT retained or recovered their fertility after transplant. In these patients, pregnancy has been a practical and safe possibility and usually had a favorable outcome as in the normal population.

Entities:  

Mesh:

Year:  2016        PMID: 27819690     DOI: 10.1038/bmt.2016.287

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Complication free survival long-term after hemopoietic cell transplantation in thalassemia.

Authors:  Emanuele Angelucci
Journal:  Haematologica       Date:  2018-07       Impact factor: 9.941

2.  Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.

Authors:  Ilhem Rahal; Claire Galambrun; Yves Bertrand; Nathalie Garnier; Catherine Paillard; Pierre Frange; Corinne Pondarré; Jean Hugues Dalle; Regis Peffault de Latour; Mauricette Michallet; Dominique Steschenko; Despina Moshous; Patrick Lutz; Jean Louis Stephan; Pierre Simon Rohrlich; Ibrahim Yakoub-Agha; Françoise Bernaudin; Christophe Piguet; Nathalie Aladjidi; Catherine Badens; Claire Berger; Gérard Socié; Cécile Dumesnil; Marie Pierre Castex; Marilyne Poirée; Anne Lambilliotte; Caroline Thomas; Pauline Simon; Pascal Auquier; Gérard Michel; Anderson Loundou; Imane Agouti; Isabelle Thuret
Journal:  Haematologica       Date:  2018-03-29       Impact factor: 9.941

Review 3.  Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?

Authors:  Emily Delgouffe; Aude Braye; Ellen Goossens
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

4.  Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major.

Authors:  Stella Santarone; Stefano Angelini; Annalisa Natale; Doriana Vaddinelli; Raffaele Spadano; Paola Casciani; Franco Papola; Enza Di Lembo; Giovanni Iannetti; Paolo Di Bartolomeo
Journal:  Bone Marrow Transplant       Date:  2022-08-24       Impact factor: 5.174

Review 5.  New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.

Authors:  Mara Carsote; Cristina Vasiliu; Alexandra Ioana Trandafir; Simona Elena Albu; Mihai-Cristian Dumitrascu; Adelina Popa; Claudia Mehedintu; Razvan-Cosmin Petca; Aida Petca; Florica Sandru
Journal:  Diagnostics (Basel)       Date:  2022-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.